Editas Medicine
Editas Medicine
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Gene Editing
CRISPR Technology
Genomic Medicine
Clinical Research
Rare Diseases
Editas Medicine 채용공고
채용공고 0개
현재 채용 중인 채용공고가 없습니다
마감된 채용공고
1개 포지션
Join Our Team
Remote
마감 1개월 전
제품 및 서비스
reni-cel
Gene Therapy
ED
EDIT-101
Gene Therapy
ED
EDIT-301
Cell Therapy
CR
CRISPR Gene Editing Platform
Technology Platform
ED
EDIT-201
Gene Therapy
In Vivo Gene Editing Medicines
Gene Therapy
ED
EDIT-103
Gene Therapy
IN
In Vivo Gene Editing Services
R&D Services
CR
CRISPR/Cas Gene Editing Platform
Platform Technology
EX
Ex Vivo Cell Engineering
R&D Services
EX
Ex Vivo Gene Editing Services
Research Services
EN
Engineered Natural Killer (eNK) Cell Platform
Cell Therapy
ED
EDIT-401
Gene Therapy
리더십
CS
Charlene Stern
Executive Vice President & General Counsel
KB
Kevin Bitterman
Interim President
DRL
David R. Liu
Founder
FZ
Feng Zhang
Founder
유사 기업
Gilead Sciences
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
Foster City, San Mateo County
10,001+명
상장
기업가치 $85B
234개 채용공고
Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases.
Thousand Oaks, Ventura County
10,001+명
상장
기업가치 $138B
1,634개 채용공고
Quest Diagnostics
American clinical laboratory company
Secaucus, Hudson County
10,001+명
상장
기업가치 $10.8B
Bristol-Myers Squibb
Biopharmaceutical medicines for serious diseases
New York City, New York
10,001+명
상장
기업가치 $150B
383개 채용공고
Sarepta
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Cambridge, Massachusetts
501-1,000명
상장
기업가치 $1.8B
11개 채용공고
최근 소식
All
X
News
HN
YouTube
Editas Medicine Eyes First Human Trial for CRISPR Cholesterol Therapy EDIT-401 - Yahoo Finance
Yahoo Finance
News
·
오늘
Editas Medicine, Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Stock Titan
News
·
오늘
Editas Medicine at Wells Fargo conference: a focused bet on CRISPR - Investing.com Canada
Investing.com Canada
News
·
어제
Editas Medicine Appoints Dan Ory as Chief Medical Officer - citybiz
citybiz
News
·
어제
Editas Medicine names Dan Ory as chief medical officer - Investing.com
Investing.com
News
·
어제
더 보기 (15개 남음)
전체 조회수
2
전체 지원 클릭
0
전체 모의 지원
0
전체 스크랩
0
리뷰
4.2
5개 리뷰
워라밸
4.0
보상
3.5
문화
4.3
커리어
2.8
경영진
3.5
78%
지인 추천률
장점
Supportive and collaborative team environment
Great work-life balance and flexible hours
Cutting-edge research opportunities
단점
Limited career advancement opportunities
High expectations and stress levels
Disorganized management practices
연봉 정보
38개 데이터
Director
1개 리포트
-
총 연봉
기본급
$150,000
주식
-
연락처 및 위치